Choice of a triptan for migraine therapy;Valg av triptan ved migrene

Tidsskrift for den Norske Laegeforening

Volumn 121, Issue 29, 2001, Pages 3410-3411

  Salvesen, R ^a  

^a Nevrologisk Avdeling   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ELETRIPTAN; NARATRIPTAN; RIZATRIPTAN; SEROTONIN; SEROTONIN AGONIST; SEROTONIN RECEPTOR; SUMATRIPTAN; ZOLMITRIPTAN; VASOCONSTRICTOR AGENT;

CLINICAL FEATURE; CONTROLLED STUDY; HUMAN; MIGRAINE; SHORT SURVEY; TREATMENT INDICATION; ARTICLE;

HUMANS; MIGRAINE DISORDERS; SEROTONIN AGONISTS; SUMATRIPTAN; VASOCONSTRICTOR AGENTS;

EID: 0035977102     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (11)

1. Differential distribution of 5-HT1D- and 5-HT1B-immunoreactivity within the human trigeminocerebrovascular system: Implications for the discovery of new antimigraine drugs
2. Cerebral blood flow during migraine attacks without aura and effect of sumatriptan
3. Direct evidence for central sites of action of zolmatriptan (311C90): An autoradiographic study in cat
4. Triptans and migraine: Which drug for which patient?
5. Eletriptan in acute migraine: A double-blind, placebo-controlled comparison to sumatriptan
6. Nya triptanpreparat kan hjälpa migrenpatienten
7. Treatment of mild headache in disabled migraine sufferers: Results of the spectrum study
8. A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine
9. Oral rizatriptan versus oral sumatriptan: A direct comparative study in the acute treatment of migraine
10. Comparison of rizatriptan 10 mg versus zolmitriptan 2.5 mg in the acute treatment of migraine
11. Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan